Table 1.
Characteristic | Baseline (N=8,156) |
Subjects with a second visit (N=1,623) |
---|---|---|
Age, y | 60 ± 9 | 61± 9 |
Male gender, % | 55 | 52 |
African-American race, % | 31 | 27 |
Height, cm | 170 ± 9 | 170 ± 9 |
Weight, kg | 82 ± 19 | 83 ± 18 |
Pack-years of smoking | 44 ± 25 | 44 ± 24 |
Current smoking status, % | 51 | 43 |
FEV1, L | 2.3 ± 1.0 | 2.3 ± 0.9 |
FEV1 change, ml/yr | - | −41 ± 52 |
FEV1, % predicted | 78 ± 27 | 80 ± 25 |
FVC, L | 3.4 ± 1.0 | 3.4 ± 1.0 |
FVC, % predicted | 89 ± 18 | 91 ± 17 |
FEV1/FVC ratio | 0.65 ± 0.17 | 0.66 ± 0.16 |
%LAA-950, % | 6.8 ± 10.0 | 7.1 ± 9.3 |
Lung mass, g | 902 ± 183 | 884 ± 174 |
Subjects with COPD, % | 50 | 50 |
One or more acute respiratory disease episode in the prior yr. to enrollment, % | 21 | 18 |
Data are presented as mean ± SD or proportion (%)